TY - JOUR AU - Enchev, R. I. AU - Schulman, B. A. AU - Peter, M. PY - 2015 DA - 2015// TI - Protein neddylation: beyond cullin-RING ligases JO - Nat Rev Mol Cell Biol VL - 16 UR - https://doi.org/10.1038/nrm3919 DO - 10.1038/nrm3919 ID - Enchev2015 ER - TY - JOUR AU - Sarkaria, I. AU - O-charoenrat, P. AU - Talbot, S. G. AU - Reddy, P. G. AU - Ngai, I. AU - Maghami, E. PY - 2006 DA - 2006// TI - Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-2074 DO - 10.1158/0008-5472.CAN-06-2074 ID - Sarkaria2006 ER - TY - JOUR AU - Li, L. AU - Wang, M. AU - Yu, G. AU - Chen, P. AU - Li, H. AU - Wei, D. PY - 2014 DA - 2014// TI - Overactivated neddylation pathway as a therapeutic target in lung cancer JO - J Natl Cancer Inst VL - 106 ID - Li2014 ER - TY - STD TI - Yu J, Huang WL, Xu QG, Zhang L, Sun SH, Zhou WP, et al. Overactivated neddylation pathway in human hepatocellular carcinoma. Cancer Med. 2018; Epub ahead of print. ID - ref4 ER - TY - JOUR AU - Huang, J. AU - Zhou, Y. AU - Thomas, G. S. AU - Gu, Z. AU - Yang, Y. AU - Xu, H. PY - 2015 DA - 2015// TI - NEDD8 inhibition overcomes CKS1B-induced drug resistance by upregulation of p21 in multiple myeloma JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-15-0254 DO - 10.1158/1078-0432.CCR-15-0254 ID - Huang2015 ER - TY - JOUR AU - Sarantopoulos, J. AU - Shapiro, G. I. AU - Cohen, R. B. AU - Clark, J. W. AU - Kauh, J. S. AU - Weiss, G. J. PY - 2016 DA - 2016// TI - Phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with advanced solid tumors JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1338 DO - 10.1158/1078-0432.CCR-15-1338 ID - Sarantopoulos2016 ER - TY - JOUR AU - Shah, J. J. AU - Jakubowiak, A. J. AU - O'Connor, O. A. AU - Orlowski, R. Z. AU - Harvey, R. D. AU - Smith, M. R. PY - 2016 DA - 2016// TI - Phase I study of the novel investigational NEDD8-activating enzyme inhibitor pevonedistat (MLN4924) in patients with relapsed/refractory multiple myeloma or lymphoma JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1237 DO - 10.1158/1078-0432.CCR-15-1237 ID - Shah2016 ER - TY - JOUR AU - Swords, R. T. AU - Erba, H. P. AU - DeAngelo, D. J. AU - Bixby, D. L. AU - Altman, J. K. AU - Maris, M. PY - 2015 DA - 2015// TI - Pevonedistat (MLN4924), a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study JO - Br J Haematol VL - 169 UR - https://doi.org/10.1111/bjh.13323 DO - 10.1111/bjh.13323 ID - Swords2015 ER - TY - JOUR AU - Bhatia, S. AU - Pavlick, A. C. AU - Boasberg, P. AU - Thompson, J. A. AU - Mulligan, G. AU - Pickard, M. D. PY - 2016 DA - 2016// TI - A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma JO - Investig New Drugs VL - 34 UR - https://doi.org/10.1007/s10637-016-0348-5 DO - 10.1007/s10637-016-0348-5 ID - Bhatia2016 ER - TY - JOUR AU - Swords, R. T. AU - Coutre, S. AU - Maris, M. B. AU - Zeidner, J. F. AU - Foran, J. M. AU - Cruz, J. PY - 2018 DA - 2018// TI - Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML JO - Blood. VL - 131 UR - https://doi.org/10.1182/blood-2017-09-805895 DO - 10.1182/blood-2017-09-805895 ID - Swords2018 ER - TY - JOUR AU - Wang, J. AU - Qi, Q. AU - Zhou, W. AU - Feng, Z. AU - Huang, B. AU - Chen, A. PY - 2018 DA - 2018// TI - Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy JO - Autophagy. VL - 14 UR - https://doi.org/10.1080/15548627.2018.1501133 DO - 10.1080/15548627.2018.1501133 ID - Wang2018 ER - TY - JOUR AU - Li, X. AU - Liu, Z. AU - Xu, X. AU - Blair, C. A. AU - Sun, Z. AU - Xie, J. PY - 2012 DA - 2012// TI - Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient-derived prostate cancer xenografts in mice JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0031213 DO - 10.1371/journal.pone.0031213 ID - Li2012 ER - TY - JOUR AU - Tang, Y. AU - Li, X. AU - Liu, Z. AU - Simoneau, A. R. AU - Xie, J. AU - Zi, X. PY - 2010 DA - 2010// TI - Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth JO - Int J Cancer VL - 127 UR - https://doi.org/10.1002/ijc.25210 DO - 10.1002/ijc.25210 ID - Tang2010 ER - TY - JOUR AU - Zi, X. AU - Simoneau, A. R. PY - 2005 DA - 2005// TI - Flavokawain a, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3803 DO - 10.1158/0008-5472.CAN-04-3803 ID - Zi2005 ER - TY - JOUR AU - Chang, C. T. AU - Hseu, Y. C. AU - Thiyagarajan, V. AU - Lin, K. Y. AU - Way, T. D. AU - Korivi, M. PY - 2017 DA - 2017// TI - Chalcone flavokawain B induces autophagic-cell death via reactive oxygen species-mediated signaling pathways in human gastric carcinoma and suppresses tumor growth in nude mice JO - Arch Toxicol VL - 91 UR - https://doi.org/10.1007/s00204-017-1967-0 DO - 10.1007/s00204-017-1967-0 ID - Chang2017 ER - TY - JOUR AU - Abu, N. AU - Mohamed, N. E. AU - Yeap, S. K. AU - Lim, K. L. AU - Akhtar, M. N. AU - Zulfadli, A. J. PY - 2015 DA - 2015// TI - In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice JO - Drug Des Devel Ther VL - 9 UR - https://doi.org/10.2147/DDDT.S67976 DO - 10.2147/DDDT.S67976 ID - Abu2015 ER - TY - JOUR AU - Kuo, Y. F. AU - Su, Y. Z. AU - Tseng, Y. H. AU - Wang, S. Y. AU - Wang, H. M. AU - Chueh, P. J. PY - 2010 DA - 2010// TI - Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells JO - Free Radic Biol Med VL - 49 UR - https://doi.org/10.1016/j.freeradbiomed.2010.04.005 DO - 10.1016/j.freeradbiomed.2010.04.005 ID - Kuo2010 ER - TY - JOUR AU - Ji, T. AU - Lin, C. AU - Krill, L. S. AU - Eskander, R. AU - Guo, Y. AU - Zi, X. PY - 2013 DA - 2013// TI - Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis JO - Mol Cancer VL - 12 UR - https://doi.org/10.1186/1476-4598-12-55 DO - 10.1186/1476-4598-12-55 ID - Ji2013 ER - TY - JOUR AU - Wirbelauer, C. AU - Sutterlüty, H. AU - Blondel, M. AU - Gstaiger, M. AU - Peter, M. AU - Reymond, F. PY - 2000 DA - 2000// TI - The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts JO - EMBO J VL - 19 UR - https://doi.org/10.1093/emboj/19.20.5362 DO - 10.1093/emboj/19.20.5362 ID - Wirbelauer2000 ER - TY - JOUR AU - Malek, E. AU - Abdel-Malek, M. A. AU - Jagannathan, S. AU - Vad, N. AU - Karns, R. AU - Jegga, A. G. PY - 2017 DA - 2017// TI - Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma JO - Leukemia. VL - 31 UR - https://doi.org/10.1038/leu.2016.258 DO - 10.1038/leu.2016.258 ID - Malek2017 ER - TY - JOUR AU - Dubiel, W. PY - 2009 DA - 2009// TI - Resolving the CSN and CAND1 paradoxes JO - Mol Cell VL - 35 UR - https://doi.org/10.1016/j.molcel.2009.08.011 DO - 10.1016/j.molcel.2009.08.011 ID - Dubiel2009 ER - TY - JOUR AU - Yamoah, K. AU - Oashi, T. AU - Sarikas, A. AU - Gazdoiu, S. AU - Osman, R. AU - Pan, Z. Q. PY - 2008 DA - 2008// TI - Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tail JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0806155105 DO - 10.1073/pnas.0806155105 ID - Yamoah2008 ER - TY - JOUR AU - Chew, E. H. AU - Poobalasingam, T. AU - Hawkey, C. J. AU - Hagen, T. PY - 2007 DA - 2007// TI - Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells--evidence for cullin dimerization JO - Cell Signal VL - 19 UR - https://doi.org/10.1016/j.cellsig.2006.12.002 DO - 10.1016/j.cellsig.2006.12.002 ID - Chew2007 ER - TY - JOUR AU - Jafari, R. AU - Almqvist, H. AU - Axelsson, H. AU - Ignatushchenko, M. AU - Lundbäck, T. AU - Nordlund, P. AU - Martinez Molina, D. PY - 2014 DA - 2014// TI - The cellular thermal shift assay for evaluating drug target interactions in cells JO - Nat Protoc VL - 9 UR - https://doi.org/10.1038/nprot.2014.138 DO - 10.1038/nprot.2014.138 ID - Jafari2014 ER - TY - STD TI - Hamid AA, Gray KP, Shaw G, MacConaill LE, Evan C, Bernard B, et al. Compound genomic alterations of TP53, PTEN, and RB1 tumor suppressors in localized and metastatic prostate Cancer. Eur Urol 2018. pii: S0302–2838(18)30949–7. doi: https://doi.org/10.1016/j.eururo.2018.11.045. [Epub ahead of print]. ID - ref25 ER - TY - JOUR AU - Gao, S. AU - Gao, Y. AU - He, H. H. AU - Han, D. AU - Han, W. AU - Avery, A. PY - 2016 DA - 2016// TI - Androgen receptor tumor suppressor function is mediated by recruitment of retinoblastoma protein JO - Cell Rep VL - 17 UR - https://doi.org/10.1016/j.celrep.2016.09.064 DO - 10.1016/j.celrep.2016.09.064 ID - Gao2016 ER - TY - JOUR AU - Beltran, H. AU - Yelensky, R. AU - Frampton, G. M. AU - Park, K. AU - Downing, S. R. AU - MacDonald, T. Y. PY - 2013 DA - 2013// TI - Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity JO - Eur Urol VL - 63 UR - https://doi.org/10.1016/j.eururo.2012.08.053 DO - 10.1016/j.eururo.2012.08.053 ID - Beltran2013 ER - TY - JOUR AU - Aparicio, A. AU - Den, R. B. AU - Knudsen, K. E. PY - 2011 DA - 2011// TI - Time to stratify? The retinoblastoma protein in castrate-resistant prostate cancer JO - Nat Rev Urol VL - 8 UR - https://doi.org/10.1038/nrurol.2011.107 DO - 10.1038/nrurol.2011.107 ID - Aparicio2011 ER - TY - JOUR AU - Sharma, A. AU - Yeow, W. S. AU - Ertel, A. AU - Coleman, I. AU - Clegg, N. AU - Thangavel, C. PY - 2010 DA - 2010// TI - The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression JO - J Clin Invest VL - 120 UR - https://doi.org/10.1172/JCI44239 DO - 10.1172/JCI44239 ID - Sharma2010 ER - TY - JOUR AU - Tan, H. L. AU - Sood, A. AU - Rahimi, H. A. AU - Wang, W. AU - Gupta, N. AU - Hicks, J. PY - 2014 DA - 2014// TI - Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-1982 DO - 10.1158/1078-0432.CCR-13-1982 ID - Tan2014 ER - TY - JOUR AU - Wang, H. AU - Bauzon, F. AU - Ji, P. AU - Xu, X. AU - Sun, D. AU - Locker, J. PY - 2010 DA - 2010// TI - Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/− mice JO - Nat Genet VL - 42 UR - https://doi.org/10.1038/ng.498 DO - 10.1038/ng.498 ID - Wang2010 ER - TY - STD TI - Brough R, Gulati A, Haider S, Kumar R, Campbell J, Knudsen E, et al. Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancer. Oncogene. 2018; Epub ahead of print. ID - ref32 ER - TY - JOUR AU - Michel, J. J. AU - Xiong, Y. PY - 1998 DA - 1998// TI - Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin a JO - Cell Growth Differ VL - 9 ID - Michel1998 ER -